M

Marc de Garidel

French businessman

Marc de Garidel is a French Biotech Entrepreneur. He is the CEO of Abivax, a French clinical-stage, publicly traded biotechnology company (ABVX at Euronext Paris and Nasdaq Global Market), which he joined in May 2023. He is also the non-executive chairman of the pharmaceutical company Ipsen since 2010.

Nº Q6755977 ★★

Poco común · Personalidades

Marc de Garidel

French businessman

Texto en inglés

Marc de Garidel is a French Biotech Entrepreneur. He is the CEO of Abivax, a French clinical-stage, publicly traded biotechnology company (ABVX at Euronext Paris and Nasdaq Global Market), which he joined in May 2023. He is also the non-executive chairman of the pharmaceutical company Ipsen since 2010.

Último precio

—

Precio mínimo

—

Mediana 7 d

—

Ventas 30 d

0

Rango 30 d

—

En circulación

0

Cotización

Ver tabla
Fechamediana MínMáxventas

Historial de ventas

Última venta
—
Media 30 d
—
Mínimo 30 d
—
Máximo 30 d
—
Ventas 7 d
0
Ventas 30 d
0

Aún no hay ventas.

Ventas anónimas: sin comprador ni vendedor. Las cifras solo cuentan ventas entre jugadores.

En Wikipedia

Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.

Marc de Garidel is a French Biotech Entrepreneur. He is the CEO of Abivax, a French clinical-stage, publicly traded biotechnology company (ABVX at Euronext Paris and Nasdaq Global Market), which he joined in May 2023. He is also the non-executive chairman of the pharmaceutical company Ipsen since 2010. He is on the board of Claris Bio, a Harvard Ophthalmology spin-off.

Texto: Wikipedia en inglés, CC BY-SA 4.0. ·

Cartas cercanas

Ver la ficha

Confirmación